These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19339805)

  • 61. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis.
    Navarro A; Valero A; Rosales MJ; Mullol J
    J Investig Allergol Clin Immunol; 2011; 21(5):363-9. PubMed ID: 21905499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
    Frank H; Gillen M; Rohatagi SS; Lim J; George G;
    J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classifications.
    Valero A; Izquierdo I; Sastre J; Navarro AM; Baró E; Martí-Guadaño E; Ferrer M; Dávila I; del Cuvillo A; Colás C; Antépara I; Alonso J; Mullol J;
    J Investig Allergol Clin Immunol; 2013; 23(1):14-9. PubMed ID: 23653969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ebastine (kestine 20) in therapy of allergic rhinitis].
    Petrovskaia TIu; Sergeeva TA; Lopatin AS
    Vestn Otorinolaringol; 2007; (3):51-3. PubMed ID: 17768822
    [No Abstract]   [Full Text] [Related]  

  • 65. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires.
    Okuda M; Ohkubo K; Goto M; Okamoto H; Konno A; Baba K; Ogino S; Enomoto M; Imai T; So N; Ishikawa Y; Takenaka Y; Manndai T; Crawford B
    Acta Otolaryngol; 2005 Jul; 125(7):736-44. PubMed ID: 16012036
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Therapy of allergic rhinitis: recommendations of US-American experts. Critical evaluation of 1st generation antihistaminics].
    MMW Fortschr Med; 1999 Nov; 141(44):46, 48. PubMed ID: 10912146
    [No Abstract]   [Full Text] [Related]  

  • 68. Key nasal symptoms predicting a positive skin test in allergic rhinitis and patient characteristics according to ARIA classification.
    Chaiyasate S; Roongrotwattanasiri K; Fooanant S; Sumitsawan Y
    J Med Assoc Thai; 2009 Mar; 92(3):377-81. PubMed ID: 19301732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: focus on the choice of anti-H1 drugs.
    Moneret-Vautrin DA; de Chillou C; Codreanu A
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):347-50. PubMed ID: 17274518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials.
    Clark J; Schall R
    Allergy; 2007 Sep; 62(9):1023-8. PubMed ID: 17686105
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dissemination and implementation of the ARIA guidelines for allergic rhinitis in general practice.
    Van Hoecke H; Vandeplas G; Acke F; Thas O; De Sutter A; Gevaert P; Van Cauwenberge P; Dhooge I
    Int Arch Allergy Immunol; 2014; 163(2):106-13. PubMed ID: 24296744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis.
    Humbert M; Boulet LP; Niven RM; Panahloo Z; Blogg M; Ayre G
    Allergy; 2009 Jan; 64(1):81-4. PubMed ID: 19076535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment.
    Vent J; Lehmacher W
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):222-7. PubMed ID: 19454884
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical observations and seven-and-one-half-year follow-up of patients using an integrative holistic approach for treating chronic sinusitis.
    Ivker RS; Silvers WS; Anderson RA
    Altern Ther Health Med; 2009; 15(1):36-43. PubMed ID: 19161046
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey.
    Maurer M; Zuberbier T
    Allergy; 2007 Sep; 62(9):1057-63. PubMed ID: 17581263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effects of acupuncture preventive treatment on the quality of life in patients of no-aura migraine].
    Zhang Y; Zhang L; Li B; Wang LP
    Zhongguo Zhen Jiu; 2009 Jun; 29(6):431-5. PubMed ID: 19563186
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis.
    Nishimura I; Igarashi T; Enomoto T; Dake Y; Okuno Y; Obata A
    Allergol Int; 2009 Jun; 58(2):179-85. PubMed ID: 19240374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antihistamines. How safe are they?].
    MMW Fortschr Med; 2002 Sep; 144(37):53. PubMed ID: 12380340
    [No Abstract]   [Full Text] [Related]  

  • 80. [Allergy in general practice in Arhus County. Quality assessment of diagnosis, treatment and instructions to patients: II. Rhinitis].
    Jensen JK; Jakobsen MK
    Ugeskr Laeger; 2006 Mar; 168(13):1331-6. PubMed ID: 16579889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.